USA Financial Formulas’s Arcosa ACA Stock Holding History

USA Financial Formulas’s Portfolio ACA Stock Details ACA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6	Closed	-$431	–	336
2023 Q3	$431	Buy	+6	New	+$455	﹤0.01%	458

Other funds holding ACA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

USA Financial Formulas's ACA Position: Q4 2023 in Review

USA Financial Formulas sold out of Arcosa (ACA) in Q4 2023, closing a stake of 6 shares — an estimated $431 sold.

USA Financial Formulas first reported a position in ACA in Q3 2023 and held it in 1 quarter. The position peaked at $431 in Q3 2023. 296 funds tracked by Wall St. Rank hold ACA as of Q4 2023.

USA Financial Formulas reported no remaining Arcosa position as of Q4 2023 after selling out during the quarter.
USA Financial Formulas sold 6 Arcosa shares in Q4 2023, an estimated $431.
USA Financial Formulas first reported a position in Arcosa in Q3 2023 and held it in 1 quarter.
USA Financial Formulas's Arcosa position peaked at $431 in Q3 2023.
296 funds tracked by Wall St. Rank held Arcosa as of Q4 2023.

Based on USA Financial Formulas's 13F filing for Q4 2023, filed 7 Feb 2024.